KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alnylam Pharmaceuticals (ALNY) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Alnylam Pharmaceuticals (ALNY) over the last 17 years, with Q3 2025 value amounting to 0.56.

  • Alnylam Pharmaceuticals' Asset Utilization Ratio rose 1017.3% to 0.56 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.56, marking a year-over-year increase of 1017.3%. This contributed to the annual value of 0.56 for FY2024, which is 1240.01% up from last year.
  • Alnylam Pharmaceuticals' Asset Utilization Ratio amounted to 0.56 in Q3 2025, which was up 1017.3% from 0.43 recorded in Q2 2025.
  • In the past 5 years, Alnylam Pharmaceuticals' Asset Utilization Ratio ranged from a high of 0.6 in Q2 2024 and a low of 0.17 during Q1 2021
  • In the last 5 years, Alnylam Pharmaceuticals' Asset Utilization Ratio had a median value of 0.36 in 2023 and averaged 0.38.
  • In the last 5 years, Alnylam Pharmaceuticals' Asset Utilization Ratio skyrocketed by 7884.21% in 2021 and then crashed by 2777.12% in 2025.
  • Over the past 5 years, Alnylam Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.24 in 2021, then increased by 23.47% to 0.29 in 2022, then skyrocketed by 62.74% to 0.48 in 2023, then grew by 11.67% to 0.53 in 2024, then rose by 5.53% to 0.56 in 2025.
  • Its Asset Utilization Ratio was 0.56 in Q3 2025, compared to 0.43 in Q2 2025 and 0.42 in Q1 2025.